Massachusetts Financial Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.5M Buy
166,973
+25,920
+18% +$1.79M ﹤0.01% 670
2025
Q1
$9.79M Buy
141,053
+40,945
+41% +$2.84M ﹤0.01% 662
2024
Q4
$8.61M Buy
100,108
+20,448
+26% +$1.76M ﹤0.01% 658
2024
Q3
$9.49M Buy
79,660
+2,166
+3% +$258K ﹤0.01% 640
2024
Q2
$11.1M Buy
77,494
+1,860
+2% +$265K ﹤0.01% 629
2024
Q1
$9.71M Buy
75,634
+2,775
+4% +$356K ﹤0.01% 624
2023
Q4
$7.54M Sell
72,859
-800,735
-92% -$82.8M ﹤0.01% 635
2023
Q3
$79.4M Sell
873,594
-719,472
-45% -$65.4M 0.03% 384
2023
Q2
$129M Buy
1,593,066
+1,513,672
+1,907% +$122M 0.04% 323
2023
Q1
$6.32M Buy
79,394
+3,542
+5% +$282K ﹤0.01% 631
2022
Q4
$5.13M Sell
75,852
-15,586
-17% -$1.05M ﹤0.01% 652
2022
Q3
$4.56M Sell
91,438
-5,212
-5% -$260K ﹤0.01% 656
2022
Q2
$5.39M Sell
96,650
-11,966
-11% -$667K ﹤0.01% 648
2022
Q1
$6.03M Buy
108,616
+6,862
+7% +$381K ﹤0.01% 667
2021
Q4
$5.7M Sell
101,754
-45,486
-31% -$2.55M ﹤0.01% 696
2021
Q3
$7.07M Sell
147,240
-84,840
-37% -$4.07M ﹤0.01% 689
2021
Q2
$9.72M Buy
232,080
+13,802
+6% +$578K ﹤0.01% 674
2021
Q1
$7.36M Buy
218,278
+26,926
+14% +$908K ﹤0.01% 678
2020
Q4
$6.68M Buy
191,352
+6,664
+4% +$233K ﹤0.01% 660
2020
Q3
$6.41M Buy
184,688
+6,390
+4% +$222K ﹤0.01% 655
2020
Q2
$5.84M Sell
178,298
-33,472
-16% -$1.1M ﹤0.01% 633
2020
Q1
$6.37M Buy
211,770
+13,434
+7% +$404K ﹤0.01% 623
2019
Q4
$5.74M Buy
198,336
+2,872
+1% +$83.1K ﹤0.01% 634
2019
Q3
$5.05M Sell
195,464
-7,400
-4% -$191K ﹤0.01% 656
2019
Q2
$5.18M Buy
202,864
+2,930
+1% +$74.8K ﹤0.01% 667
2019
Q1
$5.23M Buy
199,934
+23,632
+13% +$618K ﹤0.01% 660
2018
Q4
$4.06M Sell
176,302
-5,390
-3% -$124K ﹤0.01% 669
2018
Q3
$4.28M Sell
181,692
-2,042
-1% -$48.1K ﹤0.01% 678
2018
Q2
$4.24M Buy
183,734
+1,732
+1% +$39.9K ﹤0.01% 678
2018
Q1
$4.48M Buy
182,002
+42,462
+30% +$1.05M ﹤0.01% 670
2017
Q4
$3.75M Buy
139,540
+6,290
+5% +$169K ﹤0.01% 675
2017
Q3
$3.21M Buy
+133,250
New +$3.21M ﹤0.01% 677